Susan G. Komen® Unveils $26 Million Investment in Research Funding Focused on Metastatic Breast Cancer and New Treatments
Similar Posts
Artificial Intelligence Oversight of Growing Interest to Health Care Executives
Very few health systems have written formal policies addressing the use of artificial intelligence (AI), and even fewer…
Phenomix Sciences Releases Survey Findings on Patient Awareness of Obesity Treatment Options
Report examines views on GLP-1 medications, alternative therapies, and the role of patient education in treatment decisions Phenomix Sciences…
Home for the Holidays:
More Time With Family = More Stress for SomeOne-Third of Americans Take Anti-Anxiety Medications Due to Holiday Family Stress As Americans prepare for the holiday season,…
Health IT Apps Platform Paves the Way for Healthcare Providers
Not All Hospitalist Groups Are Created Equal From the first use of the term “hospitalist” in a 1996 NEJM…
